References and Notes
1a
Platt FM.
Neises GR.
Reinkensmeier GM.
Townsend JV.
Perry H.
Proia RL.
Winchester B.
Dwek RA.
Butters TD.
Science
1997,
276:
428
1b
Humphries MJ.
Matsumoto K.
White SL.
Olden K.
Proc. Natl. Acad. Sci. U.S.A.
1986,
83:
1752
2
Avalos M.
Babiano R.
Cintas P.
Jiménez JL.
Palacios JC.
Valencia C.
Tetrahedron
1993,
49:
2655
3a
Wiley PF.
Herr RR.
Jahnke H.
Chidester CG.
Mizsak SA.
Spaulding LB.
Argoudelis AD.
J. Org. Chem.
1979,
44:
9
3b
Ellestad GA.
Cosulich DB.
Broschard RW.
Martin JH.
Kunstmann MP.
Morton GO.
Lancaster JE.
Fulmor W.
Lovell FM.
J. Am. Chem. Soc.
1978,
100:
2515
4
Pérez PD.
García-Moreno MI.
Mellet CO.
García Fernández J.
Eur. J. Org. Chem.
2005,
2903
5
Kayakiri H.
Takase S.
Shibata T.
Okamoto M.
Terano H.
Hashimoto M.
J. Org. Chem.
1989,
54:
4015
6
Laufer S.
Wagner G.
Kotschenreuther D.
Angew. Chem. Int. Ed.
2002,
41:
2290
7
Morel CJ.
Helv. Chim. Acta
1961,
44:
403
8
Kovacs J.
Pinter I.
Messmer A.
Toth G.
Duddeck H.
Carbohydr. Res.
1987,
166:
101
9a
Prosperi D.
Ronchi S.
Lay L.
Rencurosi A.
Russo G.
Eur. J. Org. Chem.
2004,
395
9b
Prosperi D.
Ronchi S.
Panza L.
Rencurosi A.
Russo G.
Synlett
2004,
1529
10
Johnson HW.
Krutzsch H.
J. Org. Chem.
1967,
32:
1939
11 All new compounds have been characterized by proton and carbon NMR spectroscopy. Spectroscopic data for selected compounds.
Compound 5: [α]D
20 +52.9 (c 1, CHCl3); mp 160-162 °C. 1H NMR (400 MHz, CDCl3): δ = 2.01, 2.02, 2.06 (3 s, 9 H, 3 × OAc), 2.42 (s, 3 H, NAc), 3.74 (dt, 1 H, J = 4.0, 7.6 Hz, H-5), 4.14 (dd, 1 H, J = 7.2, 11.7 Hz, H-6a), 4.23 (dd, 1 H, J = 4.3, 11.7 Hz, H-6b), 4.56 (t, 1 H, J = 6.0 Hz, H-2), 4.96 (t, 1 H, J = 4.5 Hz, H-4), 5.19 (d, 1 H, J = 6.8 Hz, H-1), 5.62 (t, 1 H, J = 4.5 Hz, H-3), 6.73 (s, 1 H, NH). 13C NMR (100 MHz, APT, CDCl3): δ = 20.64, 20.73 (3 × CH3CO), 23.63 (NCOCH3), 53.04 (C-2), 64.30 (C-6), 64.42 (C-4), 66.59 (C-3), 74.57 (C-5), 77.17 (C-1), 155.15 (NCON), 169.14, 169.25, 170.46, 170.60 (4 acetyl C=O). Anal. Calcd for C15H20N2O9 (372.12): C, 48.39; H, 5.41; N, 7.52. Found: C, 48.21; H, 5.38; N, 7.61.
Compound 6: [α]D
20 +9.0 (c 0.25, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.96, 2.01, 2.05 (3 s, 9 H, 3 × OAc), 2.44 (s, 1 H, NAc), 3.86 (m, 1 H, H-5), 4.13 (dd, 1 H, J = 5.8, 12.1 Hz, H-6a), 4.18 (dd, 1 H, J = 3.2, 12.1 Hz, H-6b), 4.42 (dd, 1 H, J = 3.4, 7.8 Hz, H-2), 4.92 (dd, 1 H, J = 3.3, 7.6 Hz, H-4), 5.49 (s, 1 H, NH), 5.50 (d, 1 H, J = 6.7 Hz, H-1), 5.55 (t, 1 H, J = 3.4 Hz, H-3). 13C NMR (100 MHz, APT, CDCl3): δ = 20.60, 20.75, 20.83 (3 × CH3CO), 24.34 (NCOCH3), 53.62 (C-2), 63.62 (C-6), 67.02 (C-4), 67.30 (C-3), 67.76 (C-5), 76.46 (C-1), 154.82 (NCON), 169.02, 169.08, 170.50, 170.54 (4 acetyl C=O). Anal. Calcd for C15H20N2O9 (372.12): C, 48.39; H, 5.41; N, 7.52. Found: C, 48.09; H, 5.45; N, 7.41.
12 Deprotection of 5 gave the corresponding water-soluble glycosylimidazolidinone 13. Compound 5 (50 mg, 0.134 mmol) was dissolved in MeOH (1 mL), and Amberlite IRA 400 resin (OH- form freshly prepared, 100 mg) was added in one portion. After 1 h, the starting material disappeared (TLC: EtOAC-MeOH-H2O, 8:3:1). Resin was filtered off and the solvent was evaporated to give 13 quantitatively, which was purified by Sephadex chromatography with a G10-120 column (eluent: H2O) and lyophilized. Mp 154-156 °C. Selected NMR data for compound 13: 1H NMR (400 MHz, D2O): δ = 3.30 (ddd, 1 H, J = 2.5, 6.8, 9.5 Hz, H-5), 3.50 (t, 1 H, J = 9.5 Hz, H-4), 3.57 (dd, 1 H, J = 6.8, 12.2 Hz, H-6a), 3.81 (dd, 1 H, J = 2.5, 12.2 Hz, H-6b), 3.82 (dd, 1 H, J = 5.3, 9.5 Hz, H-3), 4.05 (dd, 1 H, J = 4.0, 5.3 Hz, H-2), 5.14 (d, 1 H, J = 4.0 Hz, H-1). 13C NMR (100 MHz, APT, D2O): δ = 57.79 (C-2), 60.87 (C-6), 67.19 (C-4), 70.84 (C-3), 74.65 (C-5), 81.64 (C-1), 165.03 (NCON). Anal. Calcd for C7H12N2O5 (204.18): C, 41.18; H, 5.92; N, 13.72. Found: C, 42.01; H, 5.38; N, 12.97.